[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Conditions](https://durgical.com/en/conditions/) › Liver metastases and colorectal liver metastases

# Liver metastases and colorectal liver metastases

The [liver](https://durgical.com/en/anatomy/liver/) is where many cancers [spread](https://durgical.com/en/epidemiology/change-management-making-improvements-stick/) first. For bowel cancer, liver spread can still be cured by surgery if all of it can be removed safely.

Updated Nov 19, 2026

## Quick facts

**Key signs**
Often none · Right upper quadrant discomfort

**First line**
Parenchyma-sparing resections

Red flags ↓ No doses: the clinician sets them by the current guideline.

On this page

- The basics What it is
- How to think about it
- Who gets it
- Causes
- Risk factors
- Pathophysiology
- Classification
- A liver lesion on the scan: which one?
- Common traps
- Why it happens

- Clinical Symptoms and signs
- Red flags
- Diagnosis
- Differential diagnosis
- Complications
- Prognosis

- Treatment Goal of treatment
- Treatment
- Prevention

- Study Test yourself

- Connections Connections

## What it is

Cancer that has spread to the liver from a primary tumour elsewhere. In most of the world, a malignant lesion found in a non-cirrhotic liver is far more often a metastasis than a primary liver cancer. The commonest sources are the gut organs that drain through the [portal vein](https://durgical.com/en/anatomy/hepatic-portal-vein/) (colon and [rectum](https://durgical.com/en/anatomy/rectum/), [stomach](https://durgical.com/en/anatomy/stomach/), [pancreas](https://durgical.com/en/anatomy/pancreas/), neuroendocrine tumours) and, through the hepatic artery, breast, lung, [melanoma](https://durgical.com/en/conditions/melanoma/) (especially uveal) and [kidney](https://durgical.com/en/anatomy/kidney/). Colorectal liver metastases are the classic surgical case: unlike most metastatic disease, they can be cured in selected patients by resection, often combined with chemotherapy.

## How to think about it

Follow the blood. Everything absorbed from the bowel passes through the portal vein into the liver first, so the liver is the first filter that catches cancer cells shed by gut tumours, and for [colorectal cancer](https://durgical.com/en/conditions/colorectal-cancer/) it is often the only place they settle for a while. That is why removing them can cure. Then judge resectability as a question about what is left behind, not what is taken away: can every tumour be removed with a clear margin while leaving enough healthy liver (with its own blood in, blood out and bile drainage) for the patient to live on? The number of tumours matters less than that remnant.

See it in 3D

- [Liver](https://durgical.com/en/anatomy/liver/)
- [Portal vein](https://durgical.com/en/anatomy/hepatic-portal-vein/)
- [Hepatic veins](https://durgical.com/en/anatomy/hepatic-veins/)
- [Liver segment II](https://durgical.com/en/anatomy/left-posterior-lateral-segment-of-liver/)

## +9

- [Liver segment III](https://durgical.com/en/anatomy/left-anterior-lateral-segment-of-liver/)
- [Liver segment IV](https://durgical.com/en/anatomy/left-medial-segment-of-liver/)
- [Liver segment V](https://durgical.com/en/anatomy/anterior-medial-segment-of-liver/)
- [Liver segment VI](https://durgical.com/en/anatomy/anterior-lateral-segment-of-liver/)
- [Liver segment VII](https://durgical.com/en/anatomy/posterior-lateral-segment-of-liver/)
- [Liver segment VIII](https://durgical.com/en/anatomy/posterior-medial-segment-of-liver/)
- [Proper hepatic artery](https://durgical.com/en/anatomy/proper-hepatic-artery/)
- [Inferior vena cava](https://durgical.com/en/anatomy/inferior-vena-cava/)
- [Common bile duct](https://durgical.com/en/anatomy/bile-duct/)

## Who gets it

The liver is the most common site of blood-borne metastases. About half of people with colorectal cancer develop liver metastases, a substantial minority already at diagnosis (synchronous) and the rest later (metachronous). In Colombia colorectal cancer is among the commonest cancers and its [incidence](https://durgical.com/en/epidemiology/incidence/) is rising, so colorectal liver metastases are a frequent problem for surgical and oncology teams; [hepatocellular carcinoma](https://durgical.com/en/conditions/hepatocellular-carcinoma/), by contrast, usually arises in [cirrhosis](https://durgical.com/en/conditions/cirrhosis/).

## Causes

- Colorectal cancer (most common and most often treated surgically)
- Other gut primaries draining through the portal vein: stomach, pancreas, [gallbladder](https://durgical.com/en/anatomy/gallbladder/), small bowel, gastrointestinal neuroendocrine tumours, [gastrointestinal stromal tumour](https://durgical.com/en/conditions/gastrointestinal-stromal-tumour/)
- Breast and [lung cancer](https://durgical.com/en/conditions/lung-cancer/)
- Melanoma, especially [uveal melanoma](https://durgical.com/en/conditions/uveal-melanoma/), which characteristically spreads to the liver
- Kidney, ovarian, [oesophageal cancer](https://durgical.com/en/conditions/oesophageal-cancer/) and sarcomas; sometimes an unknown primary

## Risk factors

- Advanced primary tumour stage (deep invasion, lymph node spread)
- Raised CEA before or after resection of a colorectal primary
- Biology of the primary: RAS or BRAF mutation in colorectal cancer, high-grade neuroendocrine tumours
- No or incomplete surveillance after treatment of a primary cancer

## Pathophysiology

Tumour cells invade vessels in the primary → enter the portal venous (gut) or systemic arterial circulation → are trapped in the liver sinusoids, the first capillary bed for portal blood → survive, attach and grow a new blood supply mainly from the hepatic artery → tumours enlarge, replace liver tissue and may compress bile ducts or vessels → late: jaundice, ascites, liver failure, pain from capsule stretch. Neuroendocrine tumours in the liver release hormones such as [serotonin](https://durgical.com/en/biochemistry/molecules/serotonin/) directly into the [hepatic veins](https://durgical.com/en/anatomy/hepatic-veins/), bypassing liver breakdown, which is why [carcinoid syndrome](https://durgical.com/en/conditions/carcinoid-syndrome/) appears once there are liver metastases.

## Classification

- By timing: synchronous (found with the primary) or metachronous (found later)
- By blood supply on imaging: hypovascular (most colorectal, gastric, pancreatic, lung) or hypervascular (neuroendocrine, renal cell, melanoma, thyroid, some breast)
- By resectability: resectable at presentation, potentially resectable after conversion treatment, or unresectable
- By extent: liver-only disease or liver plus extrahepatic disease (lung, [peritoneum](https://durgical.com/en/anatomy/peritoneum/), nodes)

## Symptoms and signs

- Often none: most are found on staging or surveillance scans, or by a rising CEA
- Right upper quadrant discomfort or a dragging pain from stretching of the liver capsule
- Weight loss, fatigue, loss of appetite
- Enlarged, hard, irregular liver on palpation in advanced disease
- Jaundice, ascites and confusion in extensive disease (liver failure or [bile duct](https://durgical.com/en/anatomy/bile-duct/) obstruction)
- Flushing, diarrhoea and wheeze in neuroendocrine tumours (carcinoid syndrome)

## Red flags

- Jaundice in a patient with known cancer (bile duct obstruction or liver failure)
- Rising CEA during follow-up of colorectal cancer
- A new liver lesion in a patient with any history of cancer
- Rapid liver enlargement with pain, fever or bleeding into a tumour
- Signs of liver failure: ascites, encephalopathy, coagulopathy

## Diagnosis

**Clinical**
In a patient with known cancer, a new [liver](https://durgical.com/en/anatomy/liver/) lesion is a metastasis until proven otherwise; in a patient without known cancer, look for the primary (colonoscopy, breast and [skin](https://durgical.com/en/anatomy/skin/) examination, history of eye melanoma) and check for cirrhosis, which points instead to hepatocellular carcinoma. Assess fitness for surgery and the extent of disease outside the liver.

**Tests**
Liver tests (alkaline phosphatase and GGT may rise; normal tests do not exclude metastases), CEA for colorectal cancer (baseline and follow-up), AFP to help separate hepatocellular carcinoma, CA 19-9 and other markers by suspected primary; [chromogranin A](https://durgical.com/en/endocrinology/neuroendocrine-tumours-markers-grading-and-functional-imaging/) and [urinary 5-HIAA](https://durgical.com/en/endocrinology/carcinoid-syndrome-flushing-diarrhoea-and-5-hiaa/) for neuroendocrine tumours. Biopsy is needed when the primary is unknown or the diagnosis is uncertain, but is avoided in a typical, potentially resectable colorectal metastasis because of the small risk of seeding along the needle track. Tumour molecular testing (RAS, BRAF, [mismatch repair](https://durgical.com/en/biochemistry/topics/dna-repair/) status) guides systemic therapy.

**Imaging**
Contrast CT of the [chest](https://durgical.com/en/anatomy/region/chest/), [abdomen](https://durgical.com/en/anatomy/region/abdomen/) and [pelvis](https://durgical.com/en/anatomy/region/pelvis/) stages the disease. MRI of the liver with a liver-specific (hepatobiliary) contrast agent and diffusion-weighted imaging is the most sensitive for small lesions and is used to plan surgery. Colorectal metastases are typically hypodense with rim enhancement on the portal venous phase; hypervascular metastases light up in the arterial phase. PET-CT looks for disease outside the liver before major surgery. Contrast-enhanced ultrasound and intraoperative ultrasound help characterise and find small lesions. CT volumetry measures the future liver remnant.

## Differential diagnosis

- Hepatocellular carcinoma (cirrhosis, arterial enhancement with washout, raised AFP)
- Haemangioma (peripheral nodular enhancement that fills in)
- [Focal nodular hyperplasia](https://durgical.com/en/conditions/benign-liver-lesions/) and hepatocellular adenoma
- Simple [liver cyst](https://durgical.com/en/conditions/cystic-liver-lesions-simple-cyst-polycystic-liver-mucinous-cystic-neoplasm-hydat/) or [hydatid cyst](https://durgical.com/en/conditions/echinococcosis/)
- Pyogenic or [amoebic liver abscess](https://durgical.com/en/conditions/amoebic-liver-abscess/)
- Intrahepatic [cholangiocarcinoma](https://durgical.com/en/conditions/cholangiocarcinoma/)
- Focal [fatty change](https://durgical.com/en/general-pathology/fatty-change/) or fatty sparing

## A liver lesion on the scan: which one?

| Lesion | Typical patient | Imaging clue | Decisive point |
| --- | --- | --- | --- |
| Metastasis | Known or hidden primary cancer, often several lesions | Hypodense with rim enhancement (colorectal), or bright in arterial phase (neuroendocrine) | History, primary search, MRI with liver-specific contrast; biopsy if primary unknown |
| [Haemangioma](https://durgical.com/en/conditions/benign-liver-lesions/) | Any adult, often incidental | Peripheral nodular enhancement that fills in towards the centre | Typical MRI pattern; no biopsy needed |
| [Focal nodular hyperplasia](https://durgical.com/en/conditions/benign-liver-lesions/) | Young woman, incidental | Uniform arterial enhancement with a central scar | Retains liver-specific contrast on MRI |
| [Hepatocellular carcinoma](https://durgical.com/en/conditions/hepatocellular-carcinoma/) | Cirrhosis or chronic hepatitis B | Arterial enhancement then washout | Imaging criteria in cirrhosis, AFP |
| [Pyogenic abscess](https://durgical.com/en/conditions/pyogenic-liver-abscess/) | Fever, biliary disease, diabetes | Rim-enhancing collection, sometimes with gas | Aspiration and culture |
| [Hydatid cyst](https://durgical.com/en/conditions/echinococcosis/) | Rural, contact with dogs and sheep | Cyst with daughter cysts or a floating membrane | Serology and typical imaging; never blind puncture |

## Goal of treatment

For colorectal (and selected neuroendocrine) metastases: aim for cure by removing or destroying all disease while preserving enough liver. For most other metastases, or when cure is not possible: control the cancer with systemic therapy, relieve symptoms and protect quality of life.

## Treatment

**Surgical**
Liver resection for colorectal metastases when all lesions can be removed with clear margins, leaving an adequate future liver remnant (enough healthy liver with blood inflow, outflow and bile drainage) and with no, or controllable, disease outside the liver. Parenchyma-sparing resections are preferred; synchronous primaries can be removed in one or two stages, decided by a multidisciplinary team.

**Medical**
Systemic chemotherapy (fluoropyrimidine-based combinations), around surgery or as conversion therapy to shrink unresectable disease, with targeted agents chosen by tumour biology (anti-EGFR [antibodies](https://durgical.com/en/biochemistry/enzymes/immunoglobulins/) in RAS wild-type, anti-VEGF agents) and immunotherapy for mismatch repair-deficient tumours. Treatment for metastases from other primaries follows that cancer's own regimens.

**Procedure**
Techniques to make more patients resectable: [portal vein](https://durgical.com/en/anatomy/hepatic-portal-vein/) embolisation (or combined portal and hepatic vein embolisation) to grow the future remnant, and two-stage hepatectomy. [Thermal ablation](https://durgical.com/en/conditions/thermal-tumour-ablation/) (radiofrequency or microwave) for small lesions, alone or with resection; stereotactic body [radiotherapy](https://durgical.com/en/nursing/radiation-therapy-skin-care-fatigue-and-safety-with-implants-and-radioactive-sou/) when ablation or surgery is not possible.

**Procedure**
Liver-directed treatment for unresectable liver-dominant disease: selective internal radiotherapy (radioembolisation), transarterial chemoembolisation (mainly for neuroendocrine metastases) or hepatic arterial infusion chemotherapy in specialist centres.

**Follow-up**
After treatment: regular CEA and cross-sectional imaging, because recurrence in the liver or lungs is common and may itself be resectable again.

**Conservative**
[Palliative care](https://durgical.com/en/anaesthesia/palliative-care-what-it-is-and-when-it-starts/) when disease is extensive or the patient is frail: control of pain, itching and ascites, biliary stenting for jaundice, and attention to nutrition and the patient's goals.

## Complications

- Liver failure from tumour replacement or after extensive resection (post-hepatectomy liver failure)
- Obstructive jaundice from bile duct compression
- Bile leak, bleeding and infection after resection
- Chemotherapy-associated [liver injury](https://durgical.com/en/conditions/liver-injury/) (fatty liver, sinusoidal injury) increasing surgical risk
- Disappearing metastases on chemotherapy that still contain cancer cells
- Recurrence in the liver or elsewhere
- Carcinoid crisis during treatment of neuroendocrine metastases

## Common traps

- **Cancer in the liver means it cannot be cured**: for colorectal cancer, complete resection of liver metastases gives long-term survival and cure in a proportion of patients
- **More than three or four metastases means unresectable**: resectability depends on whether all disease can be removed while leaving enough healthy liver, not on a fixed number of lesions
- **Every new liver lesion should be biopsied**: in a typical, potentially resectable colorectal metastasis, biopsy adds little and risks seeding; biopsy is for an unknown primary or doubtful diagnosis
- **A lesion that disappears on chemotherapy is cured**: many still hold cancer cells, so surgeons map lesions before chemotherapy and resect the original sites when possible
- **Every malignant liver lesion is hepatocellular carcinoma**: in a liver without cirrhosis, a metastasis is far more likely; search for the primary

## Prognosis

Depends on the primary. Untreated, liver metastases generally carry a poor outlook, but colorectal liver metastases that are fully resected give long-term survival in a large share of patients, and some are cured; recurrence is common but often treatable. Neuroendocrine liver metastases can have a long course. Metastases from pancreatic, gastric, lung or uveal melanoma primaries are usually treated with systemic therapy and rarely cured.

## Prevention

- Colorectal cancer screening, which finds cancers before they spread
- Structured follow-up after colorectal cancer resection (CEA and imaging) to find metastases while still resectable
- Discuss every patient with liver metastases in a multidisciplinary team including a liver surgeon, before deciding they are unresectable
- Genetic assessment for [Lynch syndrome](https://durgical.com/en/conditions/lynch-syndrome/) and other hereditary cancers

## Test yourself

Think of the answer, then tap the question to see it.

## A 62-year-old had a sigmoid cancer resected two years ago. His CEA is rising and MRI shows three lesions in the right liver. What is the next step?

Stage for extrahepatic disease (CT chest, often PET-CT) and discuss in a multidisciplinary team with a liver surgeon; if the liver remnant is adequate, resection, often with chemotherapy, can be curative.

## Why is the liver the commonest site of metastasis for colorectal cancer?

Venous blood from the colon drains through the portal vein, so the liver sinusoids are the first capillary bed to trap tumour cells shed from the primary.

## What decides whether colorectal liver metastases are resectable?

Whether all tumours can be removed with clear margins while leaving an adequate future liver remnant with inflow, outflow and bile drainage, in a fit patient with no uncontrollable disease elsewhere.

## Why does carcinoid syndrome appear only once a neuroendocrine tumour of the gut has spread to the liver?

Hormones from a gut primary pass through the portal vein to the liver, which inactivates them; liver metastases release them straight into the hepatic veins and systemic circulation.

## The future liver remnant is too small for a planned hepatectomy. What can be done?

Portal vein embolisation of the side to be removed makes the remaining liver grow; a two-stage hepatectomy or combining resection with ablation are other options.

[Add to my cards (5)](https://durgical.app/estudiar/?add=/en/conditions/liver-metastases-and-colorectal-liver-metastases/)

## Why it happens

- [Metastases to the liver: the most common liver malignancy](https://durgical.com/en/general-pathology/metastases-to-the-liver-the-most-common-liver-malignancy/)
- [Colorectal adenocarcinoma](https://durgical.com/en/general-pathology/colorectal-adenocarcinoma/)
- [Invasion and metastasis: the metastatic cascade, step by step](https://durgical.com/en/general-pathology/invasion-and-metastasis-the-metastatic-cascade-step-by-step/)
- [Pathways of spread and the usual metastatic sites](https://durgical.com/en/general-pathology/pathways-of-spread-and-the-usual-metastatic-sites/)

## Connections

## Related conditions 16

- [Colorectal cancer](https://durgical.com/en/conditions/colorectal-cancer/)
- [Carcinoma of unknown primary](https://durgical.com/en/conditions/carcinoma-of-unknown-primary/)
- [Hepatocellular carcinoma](https://durgical.com/en/conditions/hepatocellular-carcinoma/)
- [Benign liver lesions (haemangioma, focal nodular hyperplasia, adenoma)](https://durgical.com/en/conditions/benign-liver-lesions/)
- [Pyogenic liver abscess](https://durgical.com/en/conditions/pyogenic-liver-abscess/)
- [Echinococcosis (hydatid disease)](https://durgical.com/en/conditions/echinococcosis/)
- [Pancreatic neuroendocrine tumours (VIPoma, glucagonoma, somatostatinoma, non-functioning)](https://durgical.com/en/conditions/pancreatic-neuroendocrine-tumours/)
- [Carcinoid syndrome](https://durgical.com/en/conditions/carcinoid-syndrome/)
- [Uveal melanoma](https://durgical.com/en/conditions/uveal-melanoma/)
- [Breast cancer](https://durgical.com/en/conditions/breast-cancer/)
- [Gastric cancer](https://durgical.com/en/conditions/gastric-cancer/)
- [Pancreatic cancer](https://durgical.com/en/conditions/pancreatic-cancer/)

## See all 16

- [Lung cancer](https://durgical.com/en/conditions/lung-cancer/)
- [Lynch syndrome (hereditary non-polyposis colorectal cancer)](https://durgical.com/en/conditions/lynch-syndrome/)
- [Cirrhosis](https://durgical.com/en/conditions/cirrhosis/)
- [Liver transplantation and the liver transplant recipient](https://durgical.com/en/conditions/liver-transplantation-and-the-liver-transplant-recipient/)

Educational information, not medical advice. For any symptom, see a health professional.

Sources: [Liver Metastasis](https://www.ncbi.nlm.nih.gov/books/NBK553118/) (StatPearls (NCBI Bookshelf), 2023); [Colon Cancer](https://www.ncbi.nlm.nih.gov/books/NBK470380/) (StatPearls (NCBI Bookshelf), 2025); [Liver metastases: MedlinePlus Medical Encyclopedia](https://medlineplus.gov/ency/article/000277.htm) (MedlinePlus (U.S. National Library of Medicine), 2025).

[← All conditions](https://durgical.com/en/conditions/)

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/conditions/liver-metastases-and-colorectal-liver-metastases/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/conditions/liver-metastases-and-colorectal-liver-metastases/
